Ivosidenib-azacitidine in acute myeloid leukemia with IDH1R132 mutation

Bull Cancer. 2023 Oct 3:S0007-4551(23)00370-3. doi: 10.1016/j.bulcan.2023.08.008. Online ahead of print.NO ABSTRACTPMID:37798244 | DOI:10.1016/j.bulcan.2023.08.008

Source: Bulletin du Cancer - October 5, 2023 Category: Cancer & Oncology Authors: Yaquine Mechelfekh Lauris Gastaud Source Type: research